Ad
related to: Moderna
Search results
Moderna just got FDA approval for its RSV vaccine — only its second product on the market
Quartz· 3 days agoThe Food and Drug Administration on Friday approved Moderna’s mRNA-based respiratory syncytial virus...
The U.S. Government Is Close To Bankrolling Moderna's Bird Flu Jab
Investor's Business Daily· 3 days agoThe Centers for Disease Control and Prevention classifies the public health risk as low. A Moderna...
Moderna’s RSV Shot Wins FDA Approval for Use in Older Adults
Bloomberg· 3 days agoModerna Inc. gained US approval for its RSV vaccine in older adults, giving the biotech company a...
The Zacks Analyst Blog Highlights NVIDIA, Constellation Energy, Micron Technology, Moderna and...
Zacks via Yahoo Finance· 4 days agoStocks recently featured in the blog include: NVIDIA Corp. NVDA, Constellation Energy Corp. CEG,...
US approves Moderna's RSV vaccine for older adults
Medical Xpress· 3 days agoThe US Food and Drug Administration on Friday approved Moderna's respiratory syncytial virus (RSV) vaccine for older adults—marking the first time any...
Moderna secures a second FDA vaccine approval as Spikevax sales plummet
Fast Company Magazine· 2 days agoModerna announced on Friday that the U.S. Food and Drug Administration (FDA) has approved its...
FDA approves Moderna’s mRNA RSV vaccine for older adults
KTBS Shreveport· 2 days agoThe shot, made by Moderna and sold under the name of mResvia, could be another tool in the country’s RSV arsenal in the fall. Moderna’s shot is the third ...
The new technology inside COVID-19 vaccines— mRNA
KRGV Rio Grande Valley· 7 hours agoWhen you think of vaccines, you may think about traditional vaccines with weak or inactive parts of a virus to trigger an immune response. Today...
...Cuts Robinhood Holdings Amid Bitcoin Dip, Keeps Selling Moderna Stock — Buys Palantir And AMD...
Benzinga· 4 days agoOn Wednesday, Ark Invest, led by the influential investor Cathie Wood, executed notable trades...
Moderna Stock Is Having Another Very Bad Day. Here’s Why.
Barrons.com· 5 days agoThe stock’s drop comes as Moderna awaits important developments involving its experimental cancer...